Clinical Trial Update: Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee [NA]

View source ↗

Summary

A clinical study of Chondro-Gide for large chondral lesions in the knee was terminated; sponsor Geistlich Pharma AG status update indicated the trial has ended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of Knee
• Knee Injury
• Knee Pain

Drugs mentioned

• Chondro-Gide

Snippet

Sponsor: Geistlich Pharma AG | Conditions: Knee Injuries, Cartilage Injury | NA | Status: TERMINATED